Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Close this folder12. Evaluating quality and usefulness
View the document12.1 Introduction
View the document12.2 Evaluation brings many benefits
View the document12.3 Three approaches: audit, feedback and impact assessment
View the document12.4 Start with your own evaluation of the bulletin
Open this folder and view contents12.5 Assessing readers' opinions of the bulletin
View the document12.6 Evaluating the impact of the bulletin
View the document12.7 Feedback is achievable and invaluable
View the document12.8 Simple observations can tell a lot
View the document12.9 References
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information
 

12.8 Simple observations can tell a lot

Changing prescription, dispensing and consumption habits is extremely difficult and it probably cannot be achieved by a bulletin alone. By simply paying attention to events such as these experienced by some bulletins, you can guess that your own bulletin has some impact:

• the complaints of companies about the “disastrous impact of the article on the launch” of their last new product;

• the complaints of the regulatory agency who felt “obliged to take a decision” because you raised the point in a particular article;

• the number of journalists asking for advice on a drug’s efficacy or side effects;

• the increase in the number of paying subscribers, or of those who ask for permanent subscription renewal, etc.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014